{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T07:24:22Z","timestamp":1771572262781,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["tuberculosisjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.tube.2015.04.011","type":"journal-article","created":{"date-parts":[[2015,5,9]],"date-time":"2015-05-09T07:27:35Z","timestamp":1431156455000},"page":"415-420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Serum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis"],"prefix":"10.1016","volume":"95","author":[{"given":"A.","family":"Jayakumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Vittinghoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.R.","family":"Segal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7723-0339","authenticated-orcid":false,"given":"W.R.","family":"MacKenzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Gitta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Saukkonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Engle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kato-Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Nahid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2015.04.011_bib1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrd3694","article-title":"Advancing the development of tuberculosis therapy","volume":"11","author":"Zumla","year":"2012","journal-title":"Nat Rev Drug Discov"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.tube.2015.04.011_bib2","doi-asserted-by":"crossref","first-page":"S250","DOI":"10.1093\/infdis\/jis041","article-title":"Innovative trial designs are practical solutions for improving the treatment of tuberculosis","volume":"205","author":"Phillips","year":"2012","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.tube.2015.04.011_bib3","first-page":"455","article-title":"Suspected pulmonary tuberculosis in rural South Africa\u2013sputum induction as a simple diagnostic tool?","volume":"92","author":"Hartung","year":"2002","journal-title":"S\u00a0Afr Med J"},{"key":"10.1016\/j.tube.2015.04.011_bib4","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/S0140-6736(10)60359-5","article-title":"Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice","volume":"375","author":"Wallis","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2015.04.011_bib5","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1473-3099(09)70042-8","article-title":"Biomarkers for tuberculosis disease activity, cure, and relapse","volume":"9","author":"Wallis","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tube.2015.04.011_bib6","first-page":"175","article-title":"Neopterin as a marker for cell-mediated immunity in patients with pulmonary tuberculosis","volume":"1","author":"Immanuel","year":"1997","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.tube.2015.04.011_bib7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF02715666","article-title":"Neopterin as an index of immune response in patients with tuberculosis","volume":"162","author":"Fuchs","year":"1984","journal-title":"Lung"},{"key":"10.1016\/j.tube.2015.04.011_bib8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/PL00007615","article-title":"Neopterin levels and pulmonary tuberculosis in infants","volume":"176","author":"Horak","year":"1998","journal-title":"Lung"},{"key":"10.1016\/j.tube.2015.04.011_bib9","first-page":"185","article-title":"Serial evaluation of serum neopterin in HIV seronegative patients treated for tuberculosis","volume":"5","author":"Immanuel","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.tube.2015.04.011_bib10","first-page":"330","article-title":"The role of serum neopterin level in the evaluation of activation and response to treatment in the patients with pulmonary tuberculosis","volume":"54","author":"G\u00fcler","year":"2006","journal-title":"Tuberk Toraks"},{"key":"10.1016\/j.tube.2015.04.011_bib11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1620\/tjem.209.321","article-title":"Serum interleukin-2 and neopterin levels as useful markers for treatment of active pulmonary tuberculosis","volume":"209","author":"Turgut","year":"2006","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.tube.2015.04.011_bib12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2249.2006.03211.x","article-title":"Immune markers measured before treatment predict outcome of intensive phase tuberculosis therapy","volume":"146","author":"Brahmbhatt","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.tube.2015.04.011_bib13","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3109\/00365518609083733","article-title":"The non-immune inflammatory response: serial changes in plasma iron, iron-binding capacity, lactoferrin, ferritin and C-reactive protein","volume":"46","author":"Baynes","year":"1986","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.tube.2015.04.011_bib14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1183\/09031936.98.12020351","article-title":"Influence of antimicrobial chemotherapy on spirometric parameters and pro-inflammatory indices in severe pulmonary tuberculosis","volume":"12","author":"Plit","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1016\/j.tube.2015.04.011_bib15","first-page":"1010","article-title":"Prognostic value of \u201cC\u201d reactive protein in tuberculosis","volume":"26","author":"Bajaj","year":"1989","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.tube.2015.04.011_bib16","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/thx.39.3.196","article-title":"Serum amyloid A protein and C-reactive protein levels in pulmonary tuberculosis: relationship to amyloidosis","volume":"39","author":"De Beer","year":"1984","journal-title":"Thorax"},{"key":"10.1016\/j.tube.2015.04.011_bib17","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3904\/kjim.2003.18.3.138","article-title":"Changes of plasma interleukin-1 receptor antagonist, interleukin-8 and other serologic markers during chemotherapy in patients with active pulmonary tuberculosis","volume":"18","author":"Lee","year":"2003","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.tube.2015.04.011_bib18","first-page":"61","article-title":"Predicting deterioration of treated tuberculosis by corticosteroid reserve and C-reactive protein","volume":"21","author":"Scott","year":"1990","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.tube.2015.04.011_bib19","first-page":"340","article-title":"Immune parameters as markers of tuberculosis extent of disease and early prediction of anti-tuberculosis chemotherapy response","volume":"56","author":"Djoba Siawaya","year":"2008","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.tube.2015.04.011_bib20","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1164\/ajrccm\/148.5.1298","article-title":"Elevated concentrations of circulating ICAM-1 in far advanced and miliary tuberculosis","volume":"148","author":"Shijubo","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.tube.2015.04.011_bib21","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1440-1843.2003.00471.x","article-title":"Elevated levels of circulating adhesion molecules in patients with active pulmonary tuberculosis","volume":"8","author":"Mukae","year":"2003","journal-title":"Respirology"},{"key":"10.1016\/j.tube.2015.04.011_bib22","first-page":"288","article-title":"Soluble intercellular adhesion molecule 1 (sICAM-1) in bronchoalveolar lavage (BAL) cell cultures and in the circulation of patients with tuberculosis, hypersensitivity pneumonitis and sarcoidosis","volume":"3","author":"B\u00e4umer","year":"1998","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.tube.2015.04.011_bib23","first-page":"686","article-title":"The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau","volume":"6","author":"Eugen-Olsen","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.tube.2015.04.011_bib24","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.tube.2011.01.001","article-title":"A\u00a0multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M.\u00a0tuberculosis","volume":"91","author":"Ruhwald","year":"2011","journal-title":"Tuberc (Edinb)"},{"key":"10.1016\/j.tube.2015.04.011_bib25","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1183\/09031936.00055508","article-title":"Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis","volume":"32","author":"Ruhwald","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.tube.2015.04.011_bib26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1756-0500-2-19","article-title":"IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay","volume":"2","author":"Ruhwald","year":"2009","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.tube.2015.04.011_bib27","doi-asserted-by":"crossref","first-page":"e3901","DOI":"10.1371\/journal.pone.0003901","article-title":"Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma?","volume":"3","author":"Redfield","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tube.2015.04.011_bib28","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0962-8479(96)90105-7","article-title":"Correlation of serum interleukin-2 receptor-alpha levels with clinical manifestations in pulmonary tuberculosis","volume":"77","author":"Rajalingam","year":"1996","journal-title":"Tuber Lung Dis"},{"key":"10.1016\/j.tube.2015.04.011_bib29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1365-2249.2000.01341.x","article-title":"Tuberculosis (TB) and HIV infection are independently associated with elevated serum concentrations of tumour necrosis factor receptor type 1 and beta2-microglobulin, respectively","volume":"122","author":"Lawn","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.tube.2015.04.011_bib30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-2249.1999.00903.x","article-title":"Soluble tumour necrosis factor (TNF)-receptor levels in serum as markers of anti-viral host reactivity","volume":"116","author":"Bartholdy","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.tube.2015.04.011_bib31","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.meegid.2011.04.025","article-title":"Polymorphism of 3\u2032 UTR region of TNFR2 coding gene and its role in clinical tuberculosis in Han Chinese pediatric population","volume":"11","author":"Mokrousov","year":"2011","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.tube.2015.04.011_bib32","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/infdis\/jis461","article-title":"Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: Study 29 of the Tuberculosis Trials Consortium","volume":"206","author":"Dorman","year":"2012","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.tube.2015.04.011_bib33","doi-asserted-by":"crossref","first-page":"e61002","DOI":"10.1371\/journal.pone.0061002","article-title":"Elucidating novel serum biomarkers associated with pulmonary tuberculosis treatment","volume":"8","author":"De Groote","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tube.2015.04.011_bib34","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A\u00a0simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"Peduzzi","year":"1996","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.tube.2015.04.011_bib35","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/aje\/kwk052","article-title":"Relaxing the rule of ten events per variable in logistic and cox regression","volume":"165","author":"Vittinghoff","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.tube.2015.04.011_bib36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/00031305.1983.10483087","article-title":"A\u00a0leisurely look at the bootstrap, the jackknife, and cross-validation","volume":"37","author":"Efron","year":"1983","journal-title":"Am Stat"},{"key":"10.1016\/j.tube.2015.04.011_bib37","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1080\/01621459.1993.10476299","article-title":"Linear model selection by cross-validation","volume":"88","author":"Shao","year":"1993","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.tube.2015.04.011_bib38","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Tutorial in biostatistics multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat Med"},{"key":"10.1016\/j.tube.2015.04.011_bib39","first-page":"340","article-title":"Resolution of the acute-phase response in West African patients receiving treatment for pulmonary tuberculosis","volume":"4","author":"Lawn","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.tube.2015.04.011_bib40","first-page":"720","article-title":"Levels of interferon-gamma and interleukin-2 receptor-alpha for bronchoalveolar lavage fluid and serum were correlated with clinical grade and treatment of pulmonary tuberculosis","volume":"6","author":"Tsao","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.tube.2015.04.011_bib41","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.trstmh.2008.11.024","article-title":"alpha1-acid glycoprotein and alpha1-antitrypsin as early markers of treatment response in patients receiving the intensive phase of tuberculosis therapy","volume":"103","author":"Almeida","year":"2009","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.tube.2015.04.011_bib42","series-title":"Regression methods in biostatistics","author":"Vittinghoff","year":"2012"},{"key":"10.1016\/j.tube.2015.04.011_bib43","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1164\/ajrccm\/147.4.1062","article-title":"Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months","volume":"147","author":"Mitchison","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.tube.2015.04.011_bib44","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1473-3099(10)70003-7","article-title":"Biomarkers for tuberculosis disease activity, cure, and relapse","volume":"10","author":"Wallis","year":"2010","journal-title":"Lancet Infect Dis"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979215207184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979215207184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T22:14:59Z","timestamp":1717884899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979215207184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1472979215207184"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2015.04.011","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2015.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}